β-Arrestin-biased ligands at seven-transmembrane receptors

TGF-β SIGNAL TRANSDUCTION

Massagué, J. (1998) · Annual Review of Biochemistry · doi:10.1146/annurev.biochem.67.1.753 · Cited by 7,556

Transduction of Receptor Signals by ß-Arrestins

Lefkowitz, R. J., & Shenoy, S. K. (2005) · Science · doi:10.1126/science.1109237 · Cited by 1,727

β-Arrestins and Cell Signaling

DeWire, S. M., Ahn, S., Lefkowitz, R. J., & Shenoy, S. K. (2007) · Annual Review of Physiology · doi:10.1146/annurev.physiol.69.022405.154749 · Cited by 1,397

β-Arrestin: a Protein that Regulates β-adrenergic Receptor Function

Lohse, M. J., Benovic, J. L., Codina, J., Caron, M. G., & Lefkowitz, R. J. (1990) · Science · doi:10.1126/science.2163110 · Cited by 1,220

Enhanced Morphine Analgesia in Mice Lacking β-Arrestin 2

Bohn, L. M., Lefkowitz, R. J., Gainetdinov, R. R., Peppel, K., Caron, M. G., & Lin, F.-T. (1999) · Science · doi:10.1126/science.286.5449.2495 · Cited by 1,077

μ-Opioid receptor desensitization by β-arrestin-2 determines morphine tolerance but not dependence

Bohn, L. M., Gainetdinov, R. R., Lin, F.-T., Lefkowitz, R. J., & Caron, M. G. (2000) · Nature · doi:10.1038/35047086 · Cited by 927

β-Arrestin-dependent, G Protein-independent ERK1/2 Activation by the β2 Adrenergic Receptor

Shenoy, S. K., Drake, M. T., Nelson, C. D., Houtz, D. A., Xiao, K., Madabushi, S., Reiter, E., Premont, R. T., Lichtarge, O., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m506576200 · Cited by 759

Independent β-arrestin 2 and G protein-mediated pathways for angiotensin II activation of extracellular signal-regulated kinases 1 and 2

Wei, H., Ahn, S., Shenoy, S. K., Karnik, S. S., Hunyady, L., Luttrell, L. M., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1834556100 · Cited by 690

Morphine Side Effects in β-Arrestin 2 Knockout Mice

Raehal, K. M., Walker, J. K. L., & Bohn, L. M. (2005) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.105.087254 · Cited by 626

Morphine Activates Opioid Receptors without Causing Their Rapid Internalization

Keith, D. E., Murray, S. R., Zaki, P. A., Chu, P. C., Lissin, D. V., Kang, L., Evans, C. J., & von Zastrow, M. (1996) · Journal of Biological Chemistry · doi:10.1074/jbc.271.32.19021 · Cited by 552

Desensitization of G-protein-coupled Receptors

Xiao, Z., Yao, Y., Long, Y., & Devreotes, P. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.3.1440 · Cited by 521

Differential Kinetic and Spatial Patterns of β-Arrestin and G Protein-mediated ERK Activation by the Angiotensin II Receptor

Ahn, S., Shenoy, S. K., Wei, H., & Lefkowitz, R. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m405878200 · Cited by 508

Role for G protein-coupled receptor kinase in agonist-specific regulation of μ-opioid receptor responsiveness

Zhang, J., Ferguson, S. S. G., Barak, L. S., Bodduluri, S. R., Laporte, S. A., Law, P.-Y., & Caron, M. G. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.12.7157 · Cited by 505

Distinct β-Arrestin- and G Protein-dependent Pathways for Parathyroid Hormone Receptor-stimulated ERK1/2 Activation

Gesty-Palmer, D., Chen, M., Reiter, E., Ahn, S., Nelson, C. D., Wang, S., Eckhardt, A. E., Cowan, C. L., Spurney, R. F., Luttrell, L. M., et al. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m513380200 · Cited by 476

Measurement of the millisecond activation switch of G protein–coupled receptors in living cells

Vilardaga, J.-P., Bünemann, M., Krasel, C., Castro, M., & Lohse, M. J. (2003) · Nature Biotechnology · doi:10.1038/nbt838 · Cited by 431

On the application of “a plausible model” of allosteric proteins to the receptor for acetylcholine

Karlin, A. (1967) · Journal of Theoretical Biology · doi:10.1016/0022-5193(67)90011-2 · Cited by 428

A β-Arrestin/Green Fluorescent Protein Biosensor for Detecting G Protein-coupled Receptor Activation

Barak, L. S., Ferguson, S. S. G., Zhang, J., & Caron, M. G. (1997) · Journal of Biological Chemistry · doi:10.1074/jbc.272.44.27497 · Cited by 428

Morphine-activated opioid receptors elude desensitization by β-arrestin

Whistler, J. L., & von Zastrow, M. (1998) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.95.17.9914 · Cited by 370

Sequential Binding of Agonists to the β2 Adrenoceptor

Swaminath, G., Xiang, Y., Lee, T. W., Steenhuis, J., Parnot, C., & Kobilka, B. K. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m310888200 · Cited by 333

Differential Desensitization, Receptor Phosphorylation, β-Arrestin Recruitment, and ERK1/2 Activation by the Two Endogenous Ligands for the CC Chemokine Receptor 7

Kohout, T. A., Nicholas, S. L., Perry, S. J., Reinhart, G., Junger, S., & Struthers, R. S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402125200 · Cited by 333

New Concepts in Drug Discovery: Collateral Efficacy and Permissive Antagonism

Kenakin, T. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1875 · Cited by 317

New Roles for β-Arrestins in Cell Signaling: Not Just for Seven-Transmembrane Receptors

Lefkowitz, R. J., Rajagopal, K., & Whalen, E. J. (2006) · Molecular Cell · doi:10.1016/j.molcel.2006.11.007 · Cited by 301

Rhodopsin: Insights from Recent Structural Studies

Sakmar, T. P., Menon, S. T., Marin, E. P., & Awad, E. S. (2002) · Annual Review of Biophysics and Biomolecular Structure · doi:10.1146/annurev.biophys.31.082901.134348 · Cited by 240

Desensitization, internalization, and signaling functions of β-arrestins demonstrated by RNA interference

Ahn, S., Nelson, C. D., Garrison, T. R., Miller, W. E., & Lefkowitz, R. J. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.262789099 · Cited by 239

Side-Chain Substitutions within Angiotensin II Reveal Different Requirements for Signaling, Internalization, and Phosphorylation of Type 1A Angiotensin Receptors

Holloway, A. C., Qian, H., Pipolo, L., Ziogas, J., Miura, S.-I., Karnik, S., Southwell, B. R., Lew, M. J., & Thomas, W. G. (2002) · Molecular Pharmacology · doi:10.1016/s0026-895x(24)12327-9 · Cited by 238

An Opioid Agonist that Does Not Induce μ-Opioid Receptor—Arrestin Interactions or Receptor Internalization

Groer, C. E., Tidgewell, K., Moyer, R. A., Harding, W. W., Rothman, R. B., Prisinzano, T. E., & Bohn, L. M. (2007) · Molecular Pharmacology · doi:10.1124/mol.106.028258 · Cited by 224

β-Arrestin2-mediated inotropic effects of the angiotensin II type 1A receptor in isolated cardiac myocytes

Rajagopal, K., Whalen, E. J., Violin, J. D., Stiber, J. A., Rosenberg, P. B., Premont, R. T., Coffman, T. M., Rockman, H. A., & Lefkowitz, R. J. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607583103 · Cited by 214

Value of novelty?

Ma, P., & Zemmel, R. (2002) · Nature Reviews Drug Discovery · doi:10.1038/nrd884 · Cited by 174

Cardiac-specific overexpression of AT1 receptor mutant lacking G q/G i coupling causes hypertrophy and bradycardia in transgenic mice

Zhai, P. (2005) · Journal of Clinical Investigation · doi:10.1172/jci25330 · Cited by 171

Multiple Active States and Oligomerization of CCR5 Revealed by Functional Properties of Monoclonal Antibodies

Blanpain, C., Vanderwinden, J., Cihak, J., Wittamer, V., Poul, E. L., Issafras, H., Stangassinger, M., Vassart, G., Marullo, S., Schlöndorff, D., et al. (2002) · Molecular Biology of the Cell · doi:10.1091/mbc.01-03-0129 · Cited by 140

Commentary

Jones, S. W. (1999) · The Journal of General Physiology · doi:10.1085/jgp.114.2.271 · Cited by 139

Real-time optical recording of β1-adrenergic receptor activation reveals supersensitivity of the Arg389 variant to carvedilol

Rochais, F., Vilardaga, J., Nikolaev, V. O., Bünemann, M., Lohse, M. J., & Engelhardt, S. H. (2007) · Journal of Clinical Investigation · doi:10.1172/jci30012 · Cited by 138

Techniques: Promiscuous Gα proteins in basic research and drug discovery

Kostenis, E., Waelbroeck, M., & Milligan, G. (2005) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2005.09.007 · Cited by 136

Discrete activation of transduction pathways associated with acetylcholine m1 receptor by several muscarinic ligands

Gurwitz, D., Haring, R., Heldman, E., Fraser, C. M., Manor, D., & Fisher, A. (1994) · European Journal of Pharmacology Molecular Pharmacology · doi:10.1016/0922-4106(94)90220-8 · Cited by 129

THE BRET2/ARRESTIN ASSAY IN STABLE RECOMBINANT CELLS: A PLATFORM TO SCREEN FOR COMPOUNDS THAT INTERACT WITH G PROTEIN-COUPLED RECEPTORS (GPCRS)*

Bertrand, L., Parent, S., Caron, M., Legault, M., Joly, E. C., Angers, S., Bouvier, M., Brown, M., Houle, B., & Ménard, L. (2002) · Journal of Receptors and Signal Transduction · doi:10.1081/rrs-120014619 · Cited by 129

Diversity in Medicinal Chemistry Space

Gorse, A. (2005) · Current Topics in Medicinal Chemistry · doi:10.2174/156802606775193310 · Cited by 126

Arrestins Block G Protein-coupled Receptor-mediated Apoptosis

Revankar, C. M., Vines, C. M., Cimino, D. F., & Prossnitz, E. R. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402121200 · Cited by 124

Identification of Allosteric Peptide Agonists of CXCR4

Sachpatzidis, A., Benton, B. K., Manfredi, J. P., Wang, H., Hamilton, A. D., Dohlman, H. G., & Lolis, E. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m204667200 · Cited by 117

Molecular mechanisms of G protein-coupled receptor signaling: role of G protein-coupled receptor kinases and arrestins in receptor desensitization and resensitization.

Zhang, J., Ferguson, S. S. G., Barak, L. S., Aber, M. J., Bruno Giros, A., Lefkowitz, R. J., & Caron, M. G. (1997) · PubMed · Cited by 116

When 7 transmembrane receptors are not G protein-coupled receptors

Rajagopal, K. (2005) · Journal of Clinical Investigation · doi:10.1172/jci26950 · Cited by 101

Receptor/β-Arrestin Complex Formation and the Differential Trafficking and Resensitization ofβ2-Adrenergic and Angiotensin II Type 1A Receptors

Anborgh, P. H., Seachrist, J. L., Dale, L. B., & Ferguson, S. S. G. (2000) · Molecular Endocrinology · doi:10.1210/mend.14.12.0565 · Cited by 100

Selective Ligand-induced Stabilization of Active and Desensitized Parathyroid Hormone Type 1 Receptor Conformations

Bisello, A., Chorev, M., Rosenblatt, M., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m202544200 · Cited by 98

Parathyroid Hormone as an Anabolic Skeletal Therapy

Rubin, M. R., & Bilezikian, J. P. (2005) · Drugs · doi:10.2165/00003495-200565170-00005 · Cited by 82

G Protein-coupled Receptor Kinase and β-Arrestin-mediated Desensitization of the Angiotensin II Type 1A Receptor Elucidated by Diacylglycerol Dynamics

Violin, J. D., DeWire, S. M., Barnes, W. G., & Lefkowitz, R. J. (2006) · Journal of Biological Chemistry · doi:10.1074/jbc.m607956200 · Cited by 81

TARGET FLEXIBILITY IN MOLECULAR RECOGNITION

Gu, W., Kofler, M., Antes, I., Freund, C., Helms, V., & McCammon, J. A. (2014) · Cited by 61

A potential novel strategy to separate therapeutic- and side-effects that are mediated via the same receptor: beta-arrestin2/G-protein coupling antagonists

Bruns, I. R., Chhum, S., Dinh, A., Doerr, H. W., Dunn, N. R., Ly, Y. T., Mitman, C. L., Rickards, H. D., del Sol, C., Wan, E. W. Y., et al. (2006) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2006.00714.x · Cited by 15

Sex differences in stress-related psychiatric disorders: neurobiological perspectives

Bangasser, D. A., & Valentino, R. J. (2014) · Frontiers in Neuroendocrinology · doi:10.1016/j.yfrne.2014.03.008 · Cited by 737

A G Protein-Biased Ligand at the μ-Opioid Receptor Is Potently Analgesic with Reduced Gastrointestinal and Respiratory Dysfunction Compared with Morphine

DeWire, S. M., Yamashita, D. S., Rominger, D. H., Liu, G., Cowan, C. L., Graczyk, T. M., Chen, X.-T., Pitis, P. M., Gotchev, D., Yuan, C., et al. (2013) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.112.201616 · Cited by 647

Mu Opioids and Their Receptors: Evolution of a Concept

Pasternak, G. W., & Pan, Y.-X. (2013) · Pharmacological Reviews · doi:10.1124/pr.112.007138 · Cited by 578

Seven Transmembrane Receptors as Shapeshifting Proteins: The Impact of Allosteric Modulation and Functional Selectivity on New Drug Discovery

Kenakin, T., & Miller, L. J. (2010) · Pharmacological Reviews · doi:10.1124/pr.108.000992 · Cited by 573

How Ligands Illuminate GPCR Molecular Pharmacology

Wacker, D., Stevens, R. C., & Roth, B. L. (2017) · Cell · doi:10.1016/j.cell.2017.07.009 · Cited by 560